Alendronate treatment of the postmenopausal osteoporotic woman: Effect of multiple dosages on bone mass and bone remodeling
- 31 August 1995
- journal article
- clinical trial
- Published by Elsevier in American Journal Of Medicine
- Vol. 99 (2), 144-152
- https://doi.org/10.1016/s0002-9343(99)80134-x
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Long-term effects of a treatment course with oral alendronate of postmenopausal osteoporosisJournal of Bone and Mineral Research, 1994
- The effects of 2-year treatment with the aminobisphosphonate alendronate on bone metabolism, bone histomorphometry, and bone strength in ovariectomized nonhuman primates.Journal of Clinical Investigation, 1993
- Bisphosphonates act on rat bone resorption through the mediation of osteoblasts.Journal of Clinical Investigation, 1993
- Bone density at various sites for prediction of hip fracturesThe Lancet, 1993
- An Empirical and Simulated Comparison of Some Tests for Detecting Progressiveness of Response with Increasing Doses of a CompoundBiometrical Journal, 1992
- BisphosphonatesDrugs, 1991
- Effect of Intermittent Cyclical Etidronate Therapy on Bone Mass and Fracture Rate in Women with Postmenopausal OsteoporosisNew England Journal of Medicine, 1990
- Diminished Rates of Bone Formation in Normal Black AdultsNew England Journal of Medicine, 1988
- Lifetime fracture risk: An approach to hip fracture risk assessment based on bone mineral density and ageJournal of Clinical Epidemiology, 1988
- BONE MASS IN POSTMENOPAUSAL WOMEN AFTER WITHDRAWAL OF OESTROGEN/GESTAGEN REPLACEMENT THERAPYThe Lancet, 1981